Ulaner G A, Hu J F, Vu T H, Giudice L C, Hoffman A R
Veterans Affairs Palo Alto Health Care System, and Department of Medicine, Stanford University, California 94304, USA.
Cancer Res. 1998 Sep 15;58(18):4168-72.
The correlation between telomerase activity, telomere lengths, and cellular replicative capacity has led to the theory that maintenance of telomere lengths by telomerase acts as a molecular clock to control replicative capacity and senescence. Regulation of this molecular clock may have applications in the treatment of cell aging and tumorigenesis, although little is presently known about the regulation of telomerase activity. To investigate possible mechanisms of regulation, we examined telomerase activity and the expression of the human telomerase RNA subunit and the human telomerase reverse transcriptase protein (hTERT) during human fetal heart, liver, and kidney development. The human telomerase RNA subunit is expressed in all three tissues at all gestational ages examined. hTERT expression correlates with telomerase activity in the liver, where both are expressed at all ages surveyed, and in the heart, where both are present until the 11th gestational week but not thereafter. However, although telomerase activity in the kidney is suppressed after the 15th gestational week, the hTERT transcript can be detected until at least the 21st week. Reverse transcription-PCR using primers within the reverse transcriptase domain of hTERT show the presence of multiple alternately spliced transcripts in these tissues, corresponding to full-length message as well as spliced messages with critical reverse transcriptase motifs deleted. Of note, telomerase activity in the kidney is only present at those gestational ages when full-length hTERT message is expressed (until approximately week 15), with spliced transcripts continuing to be expressed at later stages of development. The tissue-specific and gestational-age dependent expression of hTERT mRNA seen in human development suggests the presence of at least two regulatory mechanisms controlling the activity of telomerase: transcriptional control of the hTERT gene and alternate splicing of hTERT transcripts.
端粒酶活性、端粒长度与细胞复制能力之间的相关性引发了这样一种理论,即端粒酶维持端粒长度的作用就如同一个分子时钟,用以控制细胞的复制能力和衰老过程。尽管目前对端粒酶活性的调控知之甚少,但对这个分子时钟的调控可能在细胞衰老和肿瘤发生的治疗中具有应用价值。为了探究可能的调控机制,我们检测了人胎儿心脏、肝脏和肾脏发育过程中端粒酶活性以及人端粒酶RNA亚基和人端粒酶逆转录酶蛋白(hTERT)的表达情况。在所检测的所有胎龄阶段,人端粒酶RNA亚基在这三种组织中均有表达。在肝脏中,hTERT表达与端粒酶活性相关,在所有被调查的年龄段二者均有表达;在心脏中,二者在妊娠第11周之前均存在,但之后则不再出现。然而,尽管肾脏中的端粒酶活性在妊娠第15周后受到抑制,但至少在第21周前仍可检测到hTERT转录本。使用hTERT逆转录酶结构域内引物进行的逆转录聚合酶链反应显示,这些组织中存在多种交替剪接的转录本,对应于全长信息以及关键逆转录酶基序缺失的剪接信息。值得注意的是,肾脏中的端粒酶活性仅在全长hTERT信息表达的胎龄阶段存在(直到大约第15周),而剪接转录本在发育后期仍持续表达。在人类发育过程中观察到的hTERT mRNA的组织特异性和胎龄依赖性表达表明,至少存在两种调控端粒酶活性的机制:hTERT基因的转录调控和hTERT转录本的交替剪接。